Ask the Expert

Burden of Multiple Myeloma

Treatment resources

Clinical trials

Download the ClinTrial Refer App

Latest News

Drug Exposure, Disease Characteristics Not Linked to Increased Mortality Risk in Patients with Multiple Myeloma Who Contracted COVID-19

This post was originally published by Cure Specific disease characteristics of, and treatments for, multiple myeloma were not associated with...
Continue Reading

Exploring the Future of CAR T-Cell Therapy in Multiple Myeloma

This post was originally published by Targeted Oncology C. Ola Landgren, MD, PhD, chief of Myeloma Service and hematologic oncologist at...
Continue Reading

Novel Agents Rouse Responses in Relapsed/Refractory Multiple Myeloma

This article was originally published by OncLive In just the past 5 years, incredible progress has been made in multiple...
Continue Reading

Despite COVID-19 limitations, fundraiser for multiple myeloma finds a way

This article was originally published on CBC ‘We still had that sense of community happening out there anyway’ Small but...
Continue Reading

NICE turns down Celgene’s Revlimid as multiple myeloma maintenance treatment

This article originally published by PharmaTimes Online The National Institute for Heath and Care Excellence (NICE) has turned down NHS...
Continue Reading

Blood Cancer Awareness Month

This September, the International Myeloma Foundation (IMF) asks you to take part in a social media campaign to raise awareness...
Continue Reading


Every quarter we’ll post news and information in our myeloma newsletter. If you would like to join the community of patients and caregivers receiving this subscribe below.